STUDI PENGGUNAAN KORTIKOSTEROID DAN DIURETIK PADA PASIEN SINDROM VENA KAVA SUPERIOR (SVKS) (Penelitian dilakukan di Ruang Rawat Inap Palem 1 dan 2 RSUD Dr. Soetomo Surabaya )

Teks penuh

(1)IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA. DAFTAR PUSTAKA. American Cancer Society. 2016. Causes, Risk Factor, and Prevention. https://www.cancer.org/cancer/non-small-cell-lung-cancer/causesrisks-prevention.html. Diakses tanggal 20 Juli 2019. American Cancer Society. 2017. What are the risk factors for thymus cancer.. https://www.cancer.org/cancer/thymus-cancer/causes-risks-. prevention/risk-factors.html. Diakses tanggal 20 Juli 2019. American Society of Health System Pharmacists. 2011. AHFS Drug Information. United States of America. Amstrong B. A., Perez C. A., Simpsom J. R. 1987. Role of irradiation in management of SVKS. Int J Radiat Oncol Bill Phys 3: 531. Beeson, M.S., 2016. Superior Vena Kava Syndrome in Emergency Medicine. Medication.. https://emedicine.medscape.com/article/760301-medication. Diakses tanggal 22 November 2018. Bennett, W.F., Altaf, F., Deslauriers, J., 2011. Anatomy of the Superior Vena Kava and Brachiocephalic Veins. Thorac Sug Clin. 21: 197203. Brzezniak, C., Oronsky, B., Carter, C.A., Thilagar, B., Caroen, S., Zeman, K., 2017. Superior Vena Kava Syndrome in a Patient with Small86 SKRIPSI. STUDI PENGGUNAAN KORTIKOSTEROID..... NAURI NABIELA ANNISA.

(2) IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA. 87. Cell Lung Cancer: A Case Report. Case Report in Oncology. 10, p. 252-257. Canadian Cancer Society. 2018. Superior Vena Cava Syndrome. https://www.cancer.ca/en/cancer-information/diagnosis-and treatment/. managing-side-effects/superior-vena-cava-. syndrome/?region=on. Diakses pada 18 Juli 2019. Chair, M., Amin, Z., Sutandyo, N., Rachman, A. dan Nugroho, P., 2014. Karakteristik dan Kesintasan 90 Hari Pasien Sindrom Vena Kava Superior di Rumah Sakit Cipto Mangunkusumo dan Rumah Sakit Kanker Dharmais. Indonesian Journal Of Chest. 1 (1), p. 27-31 Cohen, R., Mena, D., Mendoza, C., Matos, N., Karki, N., 2008. Superior Vena Kava Syndrome: A medical emergency. Int. J Angiol. 17 (1): 43-46. Countinho, A. E., Chapman, K.E., 2011. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insight. Molecular and Cellular Endocrinology, Vol. 355 (1), p. 2-13 Edginton, S. dan Fundytus, A., 2019. Hyperacute Superior Vena Kava Syndrome associated with Central Venous Catheter Insertion. Indian journal of critical care medicine: peer-reviewed, official publication of Indian Society of Critical Care Medicine, 23(3), p.152. Elsayem, A. dan Bruera, E., 2007. High-dose corticosteroids for the management of dyspnea in patients with tumor obstruction of the upper airway. Supportive Care in Cancer, 15(12), p.1437-1439.. SKRIPSI. STUDI PENGGUNAAN KORTIKOSTEROID..... NAURI NABIELA ANNISA.

(3) IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA. 88 Flounders J.A., 2003. Oncology emergency modules: superior vena kava syndrome. Oncology Nurse. 4, p. 84-90 Gupta, P. and Bhatia, V., 2008. Corticosteroid physiology and principles of therapy. The Indian Journal of Pediatrics, 75(10), p.1039. Jusuf, A., Wibawanto, A., Icksan, A.G., Syahruddin, E., Juniarti, Endardjo, S., 2018. Kanker Paru. Perhimpunan Dokter Paru Indonesia. Jakarta. Hal. 6-12 Kalra, O.P. dan Aggarwal, A., 2012. Rational use of diuretics and pathophysiology of edema. Medicine, 22. Katzung, B.G., Masters, S.B. dan Trevor, A.J., 2014. Basic and Clinical Pharmacology. 12th Ed. The Mc Graw-Hill Companies, Inc. New York-USA. p. 702 Kementerian. Kesehatan. Republik. Indonesia.. 2017.. Panduan. Penatalaksanaan Kanker Paru. Jakarta. Koelwyn, G.J., Jones, L.W., Hornsby, W. and Eves, N.D., 2012. Exercise therapy in the. management of dyspnea in patients. with. cancer. Current opinion in supportive and palliative care, 6(2), p.129 Lane, S., Wilson, S., 2015. Cancer Children Haematology Emergencies. Oxford University Hospitals. Lepper, P. M., Ott, S. R., Hoppe, H., Schumann, C., Stammberger, U., Bugalho, A., Frese, S., Schmucking, M., Blumstein, N.M., Diehm,. SKRIPSI. STUDI PENGGUNAAN KORTIKOSTEROID..... NAURI NABIELA ANNISA.

(4) IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA. 89 N., Bals, R., Hamacher, J., 2011. Superior Vena Kava Syndrome in Thoracic Malignancies. Journal of Respiratory Care. 56 (5): 653666. Molassiotis, A., Smith, J.A., Bennett, M.I., Blackhall, F., Taylor, D., Zavery, B., Harle, A., Booton, R., Rankin, E.M., Lloyd-Williams, M. and Morice, A.H., 2010. Clinical expert guidelines for the management of cough in lung cancer: report of a UK task group on cough. Cough, 6(1), p.9 Mustofa, S., dan Mardhiyah, I., 2017. Sindrom Vena Kava Superior pada Pasien dengan Tumor Mediastinum. AgromedUnila 4 (1) : 56-61 Nickloes, T.A.,. 2014.. Superior Vena. Kava. Syndrome.. http://emedicine.medscape.com/article/460865. Diakses tanggal 22 November 2018. PCNE. 2006. Classification for Drug Related Problems. Pharmaceutical Care Network European Foundation. Zuidlaren. PDPI.. 2017.. Efusi. Pleura.. http://klikpdpi.com/index.php?mod=article&sel=8187. Diakses pada tanggal 20 Juli 2019. Rachapalli, V., Boucher, L.M., 2014. Superior Vena Kava Syndrome: Role of the Interventionalist. Canadian Association of Radiologist Journal. 65: 168-176.. SKRIPSI. STUDI PENGGUNAAN KORTIKOSTEROID..... NAURI NABIELA ANNISA.

(5) IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA. 90 Rice, T.W., Rodriguez, M., Light, R.W., 2006. The Superior Vena Kava Syndrome. Medicine. 85(1): 37-42. Riskesdas,. 2018.. Hasil. Utama. Riskesdas. 2018.. http://www.depkes.go.id/resources/download/info-terkini/hasilriskesdas-2018.pdf. Diakses pada 24 Juli 2019. Siswandono. 2016. Kimia Medisinal. Edisi kedua. Airlangga University Press. Surabaya. Hal 258-261; 516-520 Stockley, I.H., 2008. Stockley’s Drug Interaction. 8th Ed. Pharmaceutical Press, London. p. 946-952, 1049-1052. Sweetman, S et al. 2009. Martindale: The Complete Drug Reference. 36th Ed. Pharmaceutical Press. London. p. 1153, 1292-1295, 13011302, 1402, 1420, 1425-1430, 1490, 1507, 1526-1529, 1539-1543. Ugras-Rey, S.S., 2014. Selected Oncologic Emergencies; Rosen`s Emergency Medicine. 8th Ed. Saunders. USA. Wilson L.D., Detterbeck, F.C., Yahalom, J., 2007. Superior Vena Kava Superior with Malignant Causes. New England Journal of Medicine. (18):1862-1869. Yellin, A., Rosen, A., Reichert, N., Lieberman, Y. 1990. Superior Vena Kava Syndrome: The Myth — the Facts. American Review of Respiratory Disease, 141(5): 1114–1118.. SKRIPSI. STUDI PENGGUNAAN KORTIKOSTEROID..... NAURI NABIELA ANNISA.

(6) IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA. 91 Yu, J.B., Wilson, L.D., Detterbeck, F.C., 2008. Superior vena kava syndrome- a proposed classification system and algorithm for management. Journal of Thoracic Oncology. 3(8): 811-814.. SKRIPSI. STUDI PENGGUNAAN KORTIKOSTEROID..... NAURI NABIELA ANNISA.

(7)